Successful treatment of Glanzmann's Thrombasthenia with recombinant activated Factor VII "NovoSeven"

被引：0
|
作者：
Keikhaei, Bijan [1 ]
机构：
[1] Ahvaz Jundishapur Univ Med Sci, Shafa Hosp, Thalassemia & Hemoglobinopathy Res Ctr, Ahvaz, Iran
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [41] Successful Use of Recombinant Factor VIIA (rFVIIa) For Surgical Hemostasis in A Boy with Glanzmann Thrombasthenia
    J Wu
    M-C Poon
    Pediatric Research, 1999, 45 : 767 - 767
  • [42] Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven®) in obstetrical haemorrhagic shock
    S Sobieszczyk
    GH Breborowicz
    B Kubiaczyk
    T Opala
    Critical Care, 7 (Suppl 2):
  • [43] Small-dose recombinant activated factor VII (NovoSeven®) in cardiac surgery
    Romagnoli, S
    Bevilacqua, S
    Gelsomino, S
    Pradella, S
    Ghilli, L
    Rostagno, C
    Gensini, GF
    Sorbara, C
    ANESTHESIA AND ANALGESIA, 2006, 102 (05): : 1320 - 1326
  • [44] A rare case of glanzmann thrombasthenia with concomitant factor VII deficiency
    Zohair, Muhammad
    Qayoom, Ahsan
    Luqman, Muhammad
    Ahmed, Muzammil
    Khan, Muhammad Talha
    ANNALS OF HEMATOLOGY, 2024, 103 (11) : 4779 - 4781
  • [45] The comparison of efficacy between recombinant activated factor VII (ARYOSEVEN®) and NOVOSEVEN® in patients with congenital factor VII deficiency
    Faranoush, M.
    Hassan, A.
    Toogeh, G.
    Karimi, M.
    Eshghi, P.
    Managchi, M. R.
    Hamid, H.
    Kamyar, K.
    Heshmat, R.
    Keykhahi, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1198 - 1199
  • [46] A COMPARISON OF EFFICACY BETWEEN RECOMBINANT ACTIVATED FACTOR VII (ARYOSEVEN™) AND NOVOSEVEN® IN PATIENTS WITH CONGENTIAL FACTOR VII DEFICIENCY
    Abolghasemi, Hasan
    Khoein, Babak
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E59 - E59
  • [47] Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven®)
    Johannessen, M
    Nielsen, G
    Nordfang, O
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S159 - S164
  • [48] Successful treatment of cyclophasphomide-induced intractable haemorrhagic cystitis with NovoSeven (recombinant activated factor VII) after allogeneic bone marrow transplantation
    Zakerinia, M
    Khojaste, HN
    Ramzi, M
    Haghshenash, M
    Karimi, M
    Ahmad, E
    BONE MARROW TRANSPLANTATION, 2004, 33 : S120 - S120
  • [49] The use of recombinant factor VIIa in a primigravida with Glanzmann's thrombasthenia during delivery
    Kale, A
    Bayhan, G
    Yalinkaya, A
    Yayla, M
    JOURNAL OF PERINATAL MEDICINE, 2004, 32 (05) : 456 - 458
  • [50] Prophylactic treatment (PT) with recombinant factor VIIa (novoseven) in factor VII deficient children
    Martinez, M. S.
    Costa, A.
    Fynn, A.
    Alba, L.
    Cuello, F.
    Schuttemberg, V.
    HAEMOPHILIA, 2008, 14 : 105 - 105
12345